CORCEPT THERAPEUTICS INC (CORT) › Cost of RevenueCORCEPT THERAPEUTICS INC (CORT) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $2.06M2017: $3.55M2018: $5.21M2019: $5.50M2020: $5.58M2021: $5.28M2022: $5.38M2023: $6.48M2024: $10.88M2025: $12.98M$12.98M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$12.98M+19.3%2024$10.88M+67.9%2023$6.48M+20.4%2022$5.38M+2.0%2021$5.28M-5.4%2020$5.58M+1.4%2019$5.50M+5.5%2018$5.21M+46.7%2017$3.55M+72.7%2016$2.06M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share